anmelden
FTSE 100
10.195,37
PKT
-177,56
PKT
-1,71
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.04.20 | BP Neutral | Credit Suisse Group | |
| 02.04.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 02.04.20 | Unilever buy | Goldman Sachs Group Inc. | |
| 02.04.20 | easyJet Outperform | Credit Suisse Group | |
| 02.04.20 | International Consolidated Airlines Outperform | Credit Suisse Group | |
| 02.04.20 | BAT buy | UBS AG | |
| 02.04.20 | Prudential Neutral | JP Morgan Chase & Co. | |
| 02.04.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 02.04.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 02.04.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 02.04.20 | Rolls-Royce Neutral | UBS AG | |
| 01.04.20 | BP Underperform | RBC Capital Markets | |
| 01.04.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 01.04.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 01.04.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 01.04.20 | HSBC Underperform | RBC Capital Markets | |
| 01.04.20 | Barclays Sector Perform | RBC Capital Markets | |
| 31.03.20 | Rio Tinto Equal-Weight | Morgan Stanley | |
| 31.03.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 31.03.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 31.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 31.03.20 | WPP 2012 Neutral | Goldman Sachs Group Inc. | |
| 31.03.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 31.03.20 | GSK Neutral | Oddo BHF | |
| 31.03.20 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 31.03.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.03.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 31.03.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 30.03.20 | Prudential overweight | Morgan Stanley | |
| 30.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.03.20 | GSK buy | UBS AG | |
| 30.03.20 | Vodafone Group overweight | Barclays Capital | |
| 30.03.20 | Diageo buy | Goldman Sachs Group Inc. | |
| 30.03.20 | BT Group Underweight | Barclays Capital | |
| 30.03.20 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 30.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.03.20 | BT Group Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.